101 related articles for article (PubMed ID: 18669556)
1. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006.
Alpert HR; Koh H; Connolly GN
Tob Control; 2008 Oct; 17(5):332-8. PubMed ID: 18669556
[TBL] [Abstract][Full Text] [Related]
2. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
[TBL] [Abstract][Full Text] [Related]
3. The Association between E-Cigarette Price and TV Advertising and the Sales of Smokeless Tobacco Products in the USA.
Wang Y; Duan Z; Emery SL; Kim Y; Chaloupka FJ; Huang J
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34202723
[TBL] [Abstract][Full Text] [Related]
4. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
[TBL] [Abstract][Full Text] [Related]
5. Characterising advertising strategies and expenditures for conventional and newer smokeless tobacco products.
Emery SL; Binns S; Carter CC; Rose SW; Kostygina G
Tob Control; 2023 Nov; 32(6):795-798. PubMed ID: 35803674
[TBL] [Abstract][Full Text] [Related]
6. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry.
Stepanov I; Villalta PW; Knezevich A; Jensen J; Hatsukami D; Hecht SS
Chem Res Toxicol; 2010 Jan; 23(1):66-73. PubMed ID: 19860436
[TBL] [Abstract][Full Text] [Related]
8. 'No-Barriers' tobacco product? Selling smokeless tobacco to women, people of colour and the LGBTQ+ community in the USA.
Hendlin YH; Small S; Ling PM
Tob Control; 2023 May; 32(3):330-337. PubMed ID: 34599083
[TBL] [Abstract][Full Text] [Related]
9. Under the radar: smokeless tobacco advertising in magazines with substantial youth readership.
Morrison MA; Krugman DM; Park P
Am J Public Health; 2008 Mar; 98(3):543-8. PubMed ID: 17600263
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of the nicotine lozenge and tobacco-free snuff for smokeless tobacco reduction.
Ebbert JO; Severson HH; Croghan IT; Danaher BG; Schroeder DR
Addict Behav; 2013 May; 38(5):2140-5. PubMed ID: 23454876
[TBL] [Abstract][Full Text] [Related]
11. Levels of nicotine in dust from homes of smokeless tobacco users.
Whitehead TP; Metayer C; Park JS; Does M; Buffler PA; Rappaport SM
Nicotine Tob Res; 2013 Dec; 15(12):2045-52. PubMed ID: 23884321
[TBL] [Abstract][Full Text] [Related]
12. Characterization of physiochemical parameters & their effect on microbial content of smokeless tobacco products marketed in north India.
Shahid M; Srivastava S; Shukla P; Yadav R; Sajid M; Kumar A; Singh S; Bharadwaj M
Indian J Med Res; 2023 Nov; 158(5&6):542-551. PubMed ID: 38088421
[TBL] [Abstract][Full Text] [Related]
13. Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge.
Kotlyar M; Mendoza-Baumgart MI; Li ZZ; Pentel PR; Barnett BC; Feuer RM; Smith EA; Hatsukami DK
Tob Control; 2007 Apr; 16(2):138-42. PubMed ID: 17400953
[TBL] [Abstract][Full Text] [Related]
14. Using Exogenous Social Media Exposure Measures to Assess the Effects of Smokeless Tobacco-Related Social Media Content on Smokeless Tobacco Sales in the United States.
Kostygina G; Kim Y; Gebhardt Z; Tran H; Norris A; Page S; Borowiecki M; Rose SW; Emery S
Nicotine Tob Res; 2024 Feb; 26(Supplement_1):S49-S56. PubMed ID: 38366341
[TBL] [Abstract][Full Text] [Related]
15. In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model.
Keyser BM; Flockton H; Weidman RA; Payne R; Rowe J; Jordan KG
Toxicol Lett; 2024 Feb; 392():36-45. PubMed ID: 38142871
[TBL] [Abstract][Full Text] [Related]
16. Branding the rodeo: a case study of tobacco sports sponsorship.
Ling PM; Haber LA; Wedl S
Am J Public Health; 2010 Jan; 100(1):32-41. PubMed ID: 19910357
[TBL] [Abstract][Full Text] [Related]
17. ST product characteristics and relationships with perceptions and behaviors among rural adolescent males: a qualitative study.
Couch ET; Darius EF; Walsh MM; Chaffee BW
Health Educ Res; 2017 Dec; 32(6):537-545. PubMed ID: 29112713
[TBL] [Abstract][Full Text] [Related]
18. Oral nicotine product marketing expenditures in the USA from 2016 to 2023: trends over time by brand and targeted media outlets.
Ozga JE; Cornacchione Ross J; Hrywna M; Sharma A; Ling PM; Stanton CA
Tob Control; 2024 Mar; ():. PubMed ID: 38485232
[TBL] [Abstract][Full Text] [Related]
19. Quick nic: novel smokeless nicotine products and pediatric trends.
Dubrosa F; Sangiuolo K; Franco J; Milanaik RL
Curr Opin Pediatr; 2023 Aug; 35(4):500-512. PubMed ID: 37335274
[TBL] [Abstract][Full Text] [Related]
20. The in vitro toxicology of Swedish snus.
Coggins CR; Ballantyne M; Curvall M; Rutqvist LE
Crit Rev Toxicol; 2012 Apr; 42(4):304-13. PubMed ID: 22400986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
